SCHEMBL16674255

SCHEMBL16674255

c1ccc(-c2cccc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3cccc(-c4ccc5oc6ccccc6c5c4)n3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
PLA2G10 O15496 1/20 0.37
KMT2A Q03164 3/20 0.35
MAPK1 P28482 1/20 0.35
CHEK2 O96017 1/20 0.35
RAB9A P51151 3/20 0.34
NPC1 O15118 3/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PTPRF P10586 8/20 0.34
PTPN2 P17706 8/20 0.34
PTPN1 P18031 8/20 0.34
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12175600 0.96 CHEK2 (0.36) PLA2G2APLA2G4APLA2G10KMT2ACHEK2
SCHEMBL12455122 0.94 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KMT2AMAPK1
SCHEMBL16452326 0.93 HCRTR1 (0.35) PLA2G2APLA2G4APLA2G10KMT2AMAPK1
SCHEMBL12691567 0.93 CHEK2 (0.36) PLA2G2APLA2G4APLA2G10KMT2ACHEK2
SCHEMBL17248231 0.93 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10KMT2AMAPK1
SCHEMBL20706680 0.92 CASP3 (0.38) PLA2G2APLA2G4APLA2G10KMT2ACHEK2
SCHEMBL16674248 0.92 CHEK2 (0.34) PLA2G2APLA2G4APLA2G10KMT2AMAPK1
SCHEMBL16452315 0.91 KDM4E (0.35) PLA2G2APLA2G4APLA2G10CHEK2KDM4E
SCHEMBL16452340 0.91 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10KMT2AMAPK1
SCHEMBL24813199 0.91 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3279961-B1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MAT CO LTD (JP) 2023-07-19 EP disclosed
US-20200411772-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2020-12-31 US disclosed
US-10340460-B2 Organic electroluminescent element NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-02 US disclosed
US-20180083201-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2018-03-22 US disclosed
US-20180083201-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2018-03-22 US disclosed
EP-3279961-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Nippon Steel & Sumikin Chemical Co., Ltd. (JP) 2018-02-07 EP disclosed
US-20150115240-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-04-30 US disclosed
US-20150115240-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180083201-A1 ORGANIC ELECTROLUMINESCENT ELEMENT ELF3, LAGE3, ILF3 PLA2G2A 4330/4885PLA2G4A 4307/4885PLA2G10 4743/4885
US-10340460-B2 Organic electroluminescent element EML4, LAGE3, ELOC PLA2G2A 4271/4885PLA2G4A 4233/4885PLA2G10 4685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.